Literature DB >> 3622311

Specific effects of cyclandelate on memory.

J Ananth.   

Abstract

In an uncontrolled clinical trial of 6 weeks' duration conducted in 20 male patients, aged 49 to 68 years, with memory disorders, cyclandelate 1200 to 1600 mg daily was found to be effective in improving memory as reflected by psychiatric, psychometric and psychophysiological measurements. Treatment with cyclandelate produced clinical effects which were selective for the Wechsler Memory Scale items of visual reproduction and orientation--indicators of the declarative memory. Moreover, the improvements seen in the average auditory reaction and critical flicker fusion frequency demonstrates its effect on procedural memory. Thus, our results indicate that this drug may be therapeutically useful in memory disorders of various aetiology, and that further exploration of the place of cyclandelate in this clinical area is needed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3622311     DOI: 10.2165/00003495-198700332-00018

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  16 in total

1.  [On the action on the cerebral circulation of a product formed by the esterification of mandelic acid with 3,5,5-trimethylcyclohexanol].

Authors:  C GENTILI; E LUGARESI; G G REBUCCI
Journal:  Clin Ter       Date:  1962-05-15

2.  Mechanisms of memory.

Authors:  L R Squire
Journal:  Science       Date:  1986-06-27       Impact factor: 47.728

3.  Effect of cyclandelate on cerebral cortex perfusion-rates in cerebrovascular disease.

Authors:  M D O'Brien; N Veall
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

4.  The effect of cyclandelate on mental function in patients with arteriosclerotic brain disease.

Authors:  E W Fine; D Lewis; I Villa-Landa; C B Blakemore
Journal:  Br J Psychiatry       Date:  1970-08       Impact factor: 9.319

5.  The effects of cyclandelate on psychological test performance in patients with cerebral vascular insufficiency.

Authors:  W L Smith; J B Lowrey; J A Davis
Journal:  Curr Ther Res Clin Exp       Date:  1968-12

6.  Objective evaluation of cyclandelate in treatment of intermittent claudication associated with arteriosclerosis obliterans.

Authors:  J V Ross
Journal:  Vasc Dis       Date:  1965-09

7.  Effect of cyclandelate on mental function and cerebral blood flow in elderly patients.

Authors:  J A Ball; A R Taylor
Journal:  Br Med J       Date:  1967-08-26

8.  CYCLANDELATE (CYCLOSPASMOL) IN THE TREATMENT OF PERIPHERAL CIRCULATORY DISEASES.

Authors:  A L SMITH
Journal:  Angiology       Date:  1965-01       Impact factor: 3.619

9.  Cyclandelate: effect on circulatory measurements and exercise tolerance in chronic arterial insufficiency of the lower limbs.

Authors:  T Reich
Journal:  J Am Geriatr Soc       Date:  1977-05       Impact factor: 5.562

10.  A clinical study of a spasmolytic agent (cyclospasmol) in the treatment of elderly arteriosclerotic patients.

Authors:  P J Ward
Journal:  Ulster Med J       Date:  1965-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.